(±) -ML 209
(±) -ML 209 (compound 4n), a diphenylpropanamide, is a retinoic acid-related orphan receptor RORγ antagonist with an IC50 of 1.1 μM. (±) -ML 209 inhibits RORγt transcriptional activity with an IC50 of 300 nM in HEK293t cells. (±) -ML 209 inhibits the transcriptional activity of RORγt, but not RORα in cells. (±) -ML 209 selectively inhibits murine Th17 cell differentiation without affecting the differentiation of naïve CD4+ T cells into other lineages, including Th1 and regulatory T cells[1].
Product Specifications
CAS Number
[1334526-14-5]
UNSPSC
12352005
Target
ROR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/racemic-ml-209.html
Purity
99.87
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N(C[C@@H]1C)C[C@H](C1)C)CC(C2=CC=C3C(OCO3)=C2)C(C(O)=CC(OC)=C4)=C4OC
Molecular Formula
C25H31NO6
Molecular Weight
441.52
References & Citations
[1]Jun R Huh, et al. Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors. ACS Med Chem Lett. 2013 Jan 10;4 (1) :79-84.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-126037/racemic-ML-209-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-126037/racemic-ML-209-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RORγ
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Synechocystis sp. Iron uptake protein A2 (futA2)
Recombinant Synechocystis sp. Iron uptake protein A2 (futA2)
Recombinant Synechocystis sp. Iron uptake protein A2 (futA2)
Recombinant Synechocystis sp. Iron uptake protein A2 (futA2)
Recombinant Synechocystis sp. Iron uptake protein A2 (futA2)